Degenerative calcific aortic stenosis: A natural history

Heart

Volumn 98, Issue SUPPL. 4, 2012, Pages

  Iung, Bernard ^a   Vahanian, Alec ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA ATHEROSCLEROSIS; AORTA STENOSIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; BLOOD VESSEL CALCIFICATION; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DEGENERATIVE CALCIFIC AORTIC STENOSIS; DISEASE COURSE; DISEASE SEVERITY; GEOGRAPHIC DISTRIBUTION; HIGH RISK PATIENT; HOSPITALIZATION COST; HUMAN; LIFE EXPECTANCY; MINIMALLY INVASIVE PROCEDURE; PATHOPHYSIOLOGY; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AORTIC VALVE; AORTIC VALVE STENOSIS; CALCINOSIS; CARDIOMYOPATHIES; DIAGNOSIS, DIFFERENTIAL; HUMANS;

EID: 84869023645     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-302395     Document Type: Review

References (59)

1. Soler-Soler J, Galve E. Worldwide perspective of valve disease. Heart 2000;83:721-5.
2. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on valvular heart disease. Eur Heart J 2003;24:1231-43.
3. Iung B, Baron G, Tornos P, et al. Valvular heart disease in the community: A European experience. Curr Probl Cardiol 2007;32:609-61.
4. Rajamannan NM, Evans FJ, Aikawa E, et al. Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update. Circulation 2011;124:1783-91.
5. Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol 2011;8:162-72.
6. Garg V, Muth AN, Ransom JF, et al. Mutations in NOTCH1 cause aortic valve disease. Nature 2005;437:270-4.
7. Michelena HI, Desjardins VA, Avierinos JF, et al. Natural history of asymptomatic patients with normally functioning or minimally dysfunctional bicuspid aortic valve in the community. Circulation 2008;117:2776-84.
8. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005;111:920-5.
9. Chatzizisis YS, Coskun AU, Jonas M, et al. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol 2007;49:2379-93.
10. Otto CM, Kuusisto J, Reichenbach DD, et al. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994;90:844-53.
11. Parolari A, Loardi C, Mussoni L, et al. Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention. Eur J Cardiothorac Surg 2009;35:493-504.
12. Rajamannan NM, Subramaniam M, Rickard D, et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003;107:2181-4.
13. Miller JD, Weiss RM, Heistad DD. Calcific aortic valve stenosis: methods, models, and mechanisms. Circ Res 2011;108:1392-412.
14. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997;29:630-4.
15. Chan KL, Ghani M, Woodend K, et al. Case-controlled study to assess risk factors for aortic stenosis in congenitally bicuspid aortic valve. Am J Cardiol 2001;88:690-3.
16. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005;352:2389-97.
17. Rossebo AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008;359:1343-56.
18. Chan KL, Teo K, Dumesnil JG, et al. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 2010;121:306-14.
19. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11.
20. Lindroos M, Kupari M, Heikkila J, et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993;21:1220-5.
21. Probst V, Le Scouarnec S, Legendre A, et al. Familial aggregation of calcific aortic valve stenosis in the western part of France. Circulation 2006;113:856-60.
22. Cosmi JE, Kort S, Tunick PA, et al. The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening. Arch Intern Med 2002;162:2345-7.
23. Palta S, Pai AM, Gill KS, et al. New insights into the progression of aortic stenosis: implications for secondary prevention. Circulation 2000;101:2497-502.
24. Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997;95:2262-70.
25. Rosenhek R, Zilberszac R, Schemper M, et al. Natural history of very severe aortic stenosis. Circulation 2010;121:151-6.
26. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607.
27. Ben-Dor I, Pichard AD, Gonzalez MA, et al. Correlates and causes of death in patients with severe symptomatic aortic stenosis who are not eligible to participate in a clinical trial of transcatheter aortic valve implantation. Circulation 2010;122:S37-42.
28. Iung B. Management of the elderly patient with aortic stenosis. Heart 2008;94:519-24.
29. US Census Bureau. The 2012 Statistical abstract. The National databook. Population. Resident population by sex and age. http://www.census.gov/compendia/ statab/2012/tables/12s0007.pdf
30. Institut National de la Statistique et des Etudes Economiques (INSEE). Evolution et structure de la population. Population par sexe et groupes d'âges quinquennaux. http://www.insee.fr/fr/themes/tableau.asp?reg-id= 0&ref-id=NATnon02150
31. Institut National de la Statistique et des Etudes Economiques (INSEE). Evolution et structure de la population. Projection de population à l'horizon 2060 et structure par âge. http://www.insee.fr/fr/themes/ tableau.asp?reg-id=0&ref-id=NATTEF02164
32. European Commission. Directorate-General for Employment SAaIE, the Statistical Office of the European Union. Commission staff working document. Demography Report 2010. http://epp.eurostat.ec.europa.eu/portal/page/portal/ population/documents/Tab/report.pdf
33. Garbarz E, Iung B, Caranhac G, et al. Another approach to main clinical characteristics of patients with aortic stenosis: a population based study (Abstract). Eur Heart J 2011;32(Suppl):763.
34. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005;26:2714-20.
35. Charlson E, Legedza AT, Hamel MB. Decision-making and outcomes in severe symptomatic aortic stenosis. J Heart Valve Dis 2006;15:312-21.
36. Bach DS, Cimino N, Deeb GM. Unoperated patients with severe aortic stenosis. J Am Coll Cardiol 2007;50:2018-19.
37. Freed BH, Sugeng L, Furlong K, et al. Reasons for nonadherence to guidelines for aortic valve replacement in patients with severe aortic stenosis and potential solutions. Am J Cardiol 2010;105:1339-42.
38. US Society of Thoracic Surgeons National Database. http://www.sts.org/ sites/default/files/documents/20112ndHarvestExecutiveSummary.pdf? bcsi-scan-D99544420D78AF92=0&bcsi-scan-filename= 20112ndHarvestExecutiveSummary.pdf
39. Brown JM, O 'Brien SM, Wu C, et al. Isolated aortic valve replacement in North America comprising 108 687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg 2009;137:82-90.
40. Dunning J, Gao H, Chambers J, et al. Aortic valve surgery: marked increases in volume and significant decreases in mechanical valve use-an analysis of 41 227 patients over 5 years from the Society for Cardiothoracic Surgery in Great Britain and Ireland National database. J Thorac Cardiovasc Surg 2011;142:776-82.
41. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012;33:2451-96.
42. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008;118:e523-661.
43. Iung B. Management of asymptomatic aortic stenosis. Heart 2011;97:253-9.
44. Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr 2009;10:1-25.
45. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
46. Lee SJ, Lindquist K, Segal MR, et al. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 2006;295:801-8.
47. Gagne JJ, Glynn RJ, Avorn J, et al. A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol 2011;64:749-59.
48. Rosenhek R, Iung B, Tornos P, et al. ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease. Eur Heart J 2012;33:822-8. (Epub ahead of print).
49. Malaisrie SC, Tuday E, Lapin B, et al. Transcatheter aortic valve implantation decreases the rate of unoperated aortic stenosis. Eur J Cardiothorac Surg 2011;40:43-8.
50. Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association for Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). EuroIntervention 2008;4:193-9.
51. Thomas M, Schymik G, Walther T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011;124:425-33.
52. Grant SW, Devbhandari MP, Grayson AD, et al. What is the impact of providing a transcatheter aortic valve implantation service on conventional aortic valve surgical activity: patient risk factors and outcomes in the first 2 years. Heart 2010;96:1633-7.
53. Arnaoutakis GJ, George TJ, Alejo DE, et al. Society of Thoracic Surgeons Risk Score predicts hospital charges and resource use after aortic valve replacement. J Thorac Cardiovasc Surg 2011;142:650-5.
54. Gilard M. France II: FRench Aortic National Corevalve and Edwards registry II. Communication at the ESC Congress 2011 Clinical Registry Highlight 2011.
55. Watt M, Mealing S, Eaton J, et al. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart 2012;98:370-6.
56. Reynolds MR, Magnuson EA, Wang K, et al. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis/clinical perspective: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation 2012;125:1102-9.
57. Wu Y, Grunkemeier GL, Starr A. The value of aortic valve replacement in elderly patients: an economic analysis. J Thorac Cardiovasc Surg 2007;133:603-7.
58. Wu Y, Jin R, Gao G, et al. Cost-effectiveness of aortic valve replacement in the elderly: an introductory study. J Thorac Cardiovasc Surg 2007;133:608-13.
59. Gelsomino S, Lorusso R, Livi U, et al. Cost and cost-effectiveness of cardiac surgery in elderly patients. J Thorac Cardiovasc Surg 2011;142:1062-73.